Study at a glance
What was studied?
Four studies examined vitamin D, bone growth, calcium absorption and hormones in children or adolescents. Three tested supplements; one examined associations.
What was found?
A one-year trial in girls found greater increases in selected bone measurements with supplementation. One trial raised the blood vitamin D marker without clearly improving calcium absorption. Another found no clear difference between two doses in either the marker or measured metabolic outcomes.
What does it mean?
A rise in a blood marker is different from a demonstrated improvement in body function. Starting vitamin D status and stage of growth affect how findings should be interpreted.
What are the limits?
The studies differed in age, starting status and duration. Some comparisons were small. They did not establish final adult peak bone mass or prove prevention of future fractures. Research doses are not personal recommendations.
Read the full article below ↓Adolescent growth makes vitamin D research difficult to interpret: bone size, mineral content, hormones and body composition can change while a study is running. The important question is not simply whether a blood vitamin D value rises, but whether a measured physiological outcome changes beyond the developmental changes in the comparison group. This review compares four independent adolescent studies and distinguishes bone accrual, calcium absorption and metabolic markers from eventual peak bone mass or fracture prevention. For the shorter account, read Vitamin D in Adolescent Growth and Bone Accrual: Study Summary.
Growth changes the meaning of an outcome
Bone mineral content is the amount of mineral detected in a measured region. Areal bone mineral density relates that amount to the scanned area. Neither is identical to bone strength, and neither directly records a future fracture. During growth, interpretation must consider size as well as mineral accumulation. Vitamin D and Bone provides the wider skeletal context; the studies here ask more specific questions within a changing developmental period.
An improvement within a supplemented group is not enough to establish an intervention effect. A comparison group may improve because its participants are also growing. The relevant question is whether the difference between groups supports an additional effect under the trial’s conditions. The same reasoning applies to lean mass and bone-turnover markers: change over time is an observation, whereas attribution to vitamin D requires a suitable comparison.
Developmental stage also differs from chronological age. Two participants of the same age can be at different points in maturation. A study restricted to early puberty does not directly describe all later adolescents, and findings in a small subgroup before menarche cannot simply be assigned to everyone. Vitamin D and Puberty introduces that developmental setting. The evidence below keeps each population attached to its actual measurements.
A trial of bone and lean-mass changes
El-Hajj Fuleihan and colleagues randomized 179 Lebanese girls aged 10 to 17 to placebo or two weekly vitamin D3 regimens for a year; 168 returned for scans. Selected skeletal and lean-mass findings favoured supplementation, while grip strength did not clearly improve. Results in postmenarcheal girls were null. The exploratory premenarcheal comparison contained only 34 girls, unevenly distributed across the three groups.
The study supplies evidence that maturation may matter, but numerous outcomes and small subgroups constrain precision. Some estimates weakened after adjustment for bone area or lean mass. That does not prove how the treatment worked. Table and figure subgroup tests also used different statistical methods, so their significance labels should not be interchanged. This girls report and companion reports from the larger trial are one underlying trial, not separate confirmations.
The appropriate interpretation depends on the endpoint. A regional mineral change can be meaningful evidence about that region while remaining insufficient to establish a sustained change in adult peak bone mass. Similarly, an increase in lean mass does not automatically mean improved strength. The experiment must retain its measured benefits, its null findings and its unanswered questions together. Selecting only the favourable outcome would change the scientific meaning.
Raising the precursor did not necessarily increase absorption
Lewis and colleagues’ GAPI trial randomized 323 children aged 9 to 13 to placebo or several vitamin D3 doses during 12 winter weeks. Participants were in early puberty and generally did not have severe deficiency. Blood 25-hydroxyvitamin D, or 25(OH)D, rose with dose, but estimated fractional calcium absorption and parathyroid hormone did not show corresponding treatment improvements.
Absorption was assessed using an oral stable-isotope prediction method, not direct measurement of long-term skeletal retention. Adherence was an important limitation, and the short study cannot determine eventual bone mass. GAPI companion analyses remain part of the same trial. Its distinct contribution is to show that a precursor response and a functional absorption response need not move together in this population.
Vitamin D and Calcium Physiology provides the broader calcium-regulation background. Within an intervention study, increasing an input and changing the final outcome are separate steps. If the measured blood precursor increases, the study has evidence of a biochemical response. To establish improved absorption, it must additionally show an absorption effect. One cannot supply the missing result by assuming that the biological pathway always operates in a simple dose-dependent manner.
That restraint works in both directions. A null absorption comparison does not prove that vitamin D has no role in calcium physiology. It says that the tested intervention did not establish the expected additional effect in that setting. Baseline status, developmental stage, duration and the chosen measurement all define the boundary. Treatment of severe deficiency is not answered by a trial that included few severely deficient participants.
Pubertal hormones and absorption: association is not intervention
Abrams and colleagues analysed 93 Houston adolescents after a randomized prebiotic study. The vitamin D analysis itself was observational. Dual stable isotopes measured calcium absorption, alongside blood vitamin D metabolites and parathyroid hormone, abbreviated PTH. Absorption was associated with PTH and the active vitamin D hormone, but not with 25(OH)D overall. Only one participant had a very low 25(OH)D value below 12 ng/mL.
These findings are compatible with adaptation during growth, but do not establish the direction or complete mechanism of the associations. Exploratory cutoffs and covariate choices affected some analyses. Prebiotic and genotype reports from these participants are not independent cohorts. This study adds a different type of evidence from GAPI: simultaneous hormonal relationships rather than a randomized vitamin D dose response.
Vitamin D Activation explains why a precursor measurement and an active-hormone measurement are different. The distinction is especially important when interpreting a proposed compensatory response. Observing several variables together can suggest a mechanism, but it does not isolate which variable caused another to change. A plausible physiological explanation must remain an explanation until an appropriate intervention or additional design tests it.
The study also illustrates why apparently maintained function cannot be extended to every level of deficiency or every dietary setting. A dataset with almost no severe deficiency cannot establish successful adaptation in severe deficiency. Its value is the relationship actually observed within its sampled range, not permission to assume that compensation is unlimited. The limits of the range are part of the result’s meaning.
Short-term endocrine and metabolic outcomes in sufficient adolescents
Putman and colleagues randomized 56 Boston adolescents aged 11 to 19 to two daily vitamin D3 doses for 11 weeks; 53 completed follow-up. They began above the study’s historical 25(OH)D threshold of 20 ng/mL and obesity was excluded. No clear between-group differences emerged for 25(OH)D change, PTH, bone-turnover markers, fasting glucose or insulin. Thirteen participants had received recent deficiency treatment without a washout period.
The small trial compared active doses rather than vitamin D against placebo. It was not an equivalence study and did not directly measure insulin sensitivity or long-term skeletal outcomes. Pretreatment, short duration and baseline status restrict inference. It supplies a useful metabolic-marker qualification, not proof that vitamin D cannot affect metabolism in deficient or obese adolescents.
Vitamin D and Metabolism provides the wider metabolic setting. A fasting insulin concentration is not interchangeable with every aspect of glucose regulation. Likewise, a bone-turnover marker is not a direct inventory of accumulated bone. The name of a biological system is broader than any single laboratory measurement within it. Keeping the measurement explicit prevents a narrow trial from becoming a sweeping statement about the whole system.
How the four studies fit together
The doses below describe research exposures, not personal recommendations. IU means international units. P values describe statistical evidence under a study model; they do not measure effect size or establish clinical importance.
| Study and design | Measured result | Interpretation limits |
|---|---|---|
| Fuleihan, 2006: 179 girls aged 10 to 17; one-year randomized trial | Weekly placebo, 1,400 or 14,000 IU D3. In scanned completers (55/58/55), mean total-hip bone mineral content rose 7.8%, 11.2% and 12.8%; overall P = 0.02, high dose versus placebo P = 0.005. | Baseline 25(OH)D averaged about 14 ng/mL. Variable growth and multiple skeletal comparisons complicate interpretation. Bone content is not a fracture endpoint or final peak bone mass. |
| Lewis, 2013: 323 children aged 9 to 13 in early puberty; 12-week trial | Nominal daily D3 doses: placebo, 400, 1,000, 2,000 or 4,000 IU. Model-derived asymptotic 25(OH)D gains (estimated approach to a plateau) ranged from −10 nmol/L with placebo to +76 nmol/L at the highest dose, without a clear calcium-absorption or PTH benefit. | Baseline mean 25(OH)D was 70 nmol/L and most exceeded 50. Actual assayed doses differed from labels. Results do not describe severe deficiency; adherence was imperfect. |
| Abrams, 2005: 93 young adolescents; observational vitamin D analysis | Mean age 12.6 years; calcium absorption measured with two stable isotopes. Adjusted absorption association: 25(OH)D P = 0.77; active hormone P = 0.048 and PTH P = 0.007, both positive. | Associations within a prebiotic trial, not randomized vitamin D effects. Only one participant had 25(OH)D below 12 ng/mL. Hormonal relationships do not establish an optimal target. |
| Putman, 2013: 56 adolescents aged 11 to 19; 11-week trial | Daily D3 200 versus 1,000 IU; 53 completed. Mean 25(OH)D changed from 28.1 to 28.9 versus 29.0 to 30.1 ng/mL. Between-group change P = 0.87; no clear glucose or insulin benefit. | No placebo, sufficient baseline status, obesity excluded and unequal prior treatment. Small null comparisons do not prove equal efficacy or rule out effects in other populations. |
The evidence is not a contest in which one positive study defeats several null studies, or vice versa. Different populations, exposures and endpoints can produce different findings without a logical contradiction. An effect on a selected skeletal region over a year does not require a detectable change in a short-term absorption experiment. A hormonal association does not require supplementation to alter that hormone under every starting condition.
The strongest comparison therefore asks what each design adds. The Lebanese trial measures skeletal and lean-mass change. GAPI separates precursor response from absorption. The Houston study examines hormonal relationships during puberty. The Boston study tests short-term biochemical and metabolic-marker differences in sufficient participants. Together they provide a bounded picture of adolescent physiology, while leaving important long-term and mechanistic questions open.
The general review Vitamin D and Bone: Mineralisation, Cell Signalling and Fractures: Full Study examines different evidence, including animal mechanisms and adult fracture outcomes. It supplies useful comparisons of endpoint types, but adult outcomes cannot replace adolescent data. Likewise, Vitamin D Receptors explains receptor signalling without proving a particular clinical effect in these participants. Mechanistic plausibility and demonstrated intervention benefit remain different levels of evidence.
Peak bone mass is a longer-term question
The phrase peak bone mass describes a developmental endpoint beyond a short study’s immediate measurements. A one-year increase in a bone measure does not demonstrate the final amount attained, whether a difference persists, or whether it changes later fracture risk. Those questions require follow-up appropriate to the claim. Calling an early change “peak bone mass improvement” would silently extend the observation beyond the study period.
Contemporary contrary evidence also matters. The final abstract of Ganmaa and colleagues’ large Mongolian schoolchild trial reports no clear fracture benefit from three years of supplementation. The full final paper was not available for this appraisal, so it is retained only as explicitly limited background, not counted among the four fully assessed studies or used for detailed subgroup claims. Its younger mixed-age population also differs from an exclusively adolescent cohort. No comprehensive fracture-prevention conclusion is made here.
The same caution applies to endocrine development. These four studies do not demonstrate that vitamin D initiates puberty, determines sex-hormone timing or improves every metabolic change associated with adolescence. PTH, vitamin D metabolites, glucose and insulin measurements address selected parts of the question. Unknown mechanisms should remain unknown rather than being supplied by broad language about “supporting hormones.”
Interpreting the evidence responsibly
For the reader, three questions prevent most overstatement. What changed: a blood precursor, an absorption estimate, a tissue measure or a clinical event? Who was studied: early-pubertal children, girls before or after menarche, or sufficient non-obese adolescents? What comparison was made: placebo, another active dose or an observational association? The answer to each question changes what the result can support.
Research doses describe study conditions and do not provide personal treatment instructions. Historical thresholds in the papers are not automatically current diagnostic recommendations. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D distinguishes the blood analytes; the companion status review addresses adolescent interpretation. No single concentration in these studies is shown to optimise every developmental outcome.
The evidence supports specific, context-dependent observations rather than a universal claim of skeletal or metabolic benefit. Selected bone and lean-mass changes occurred in one trial, while absorption and biochemical comparisons in other settings were null. Neither pattern should erase the other. The central scientific lesson is to connect the claim to the actual population, design, measurement and duration.
Source access and scope
The four principal reports, material tables and figure captions were assessed; the Lebanese trial’s relevant subgroup figure and tables were also visually inspected. No numerical estimate was extracted from an unseen graphic. This is a selected critical review, not a meta-analysis. Relevant unavailable trials and the Mongolian abstract do not receive full-appraisal credit. There is no claim of complete coverage of fracture prevention, pubertal sex-hormone mechanisms or obesity-specific glucose treatment.
Scientific references
Effect of Vitamin D Replacement on Musculoskeletal Parameters in School Children: A Randomized Controlled Trial. El-Hajj Fuleihan G et al. JCEM. 2006;91:405 to 412. DOI: 10.1210/jc.2005-1436. Author-hosted full text (PDF).
A Randomized Trial of Vitamin D3 Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption. Lewis RD et al. JCEM. 2013;98:4816 to 4825.
Relationships among Vitamin D Levels, Parathyroid Hormone, and Calcium Absorption in Young Adolescents. Abrams SA et al. JCEM. 2005;90:5576 to 5581.
A randomized clinical trial of vitamin D supplementation in healthy adolescents. Putman MS et al. J Adolesc Health. 2013;52:592 to 598.
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial. Ganmaa D et al. Lancet Diabetes Endocrinol. 2024;12:29 to 38. Final abstract only; not counted among the fully assessed studies.
Related reading
Adherence to Chinese Dietary Guidelines Is Associated with Better Bone Status in School-Aged Children and Adolescents
This study aimed to assess the association between diet quality scores and bone health in a pediatric population.
Original paper ↗Read more →Aflatoxin B1 Impairs Bone Mineralization in Broiler Chickens
Aflatoxin B1 (AFB1), a ubiquitous mycotoxin in corn-based animal feed, particularly in tropical regions, impairs liver function, induces oxidative stress and disrupts cellular pathways, potentially worsening bone health in modern broilers.
Original paper ↗Read more →Associations between BMI trajectories and young adult bone: a 10-yr follow-up from the Norwegian Fit Futures cohort
We aimed to investigate the associations between long-term BMI trajectories and skeletal development from adolescence into young adulthood.
Original paper ↗Read more →Effects of Dietary 25-Hydroxycholecalciferol Alone or in Combination with Vitamin D3 on Growth Performance, Blood Vitamin D Status, Immune Response, Bone Integrity, and Antioxidant Capacity of Nursery Pigs
In this study, we evaluated the effects of replacing VD3 with 25-OHD3 in diets for nursery pigs on growth, vitamin D status, bone integrity, and antioxidant capacity.
Original paper ↗Read more →Effects of sleeve gastrectomy on bone mass, microstructure of femurs and bone metabolism associated serum factors in obese rats
Bone mineral density (BMD) of trabecular bone in both HFD sham group and HFD SG group were remarkably decreased compared with control group.
Original paper ↗Read more →Effects of vitamin D supplementation during pregnancy on bone health and offspring growth: A systematic review and meta-analysis of randomized controlled trials
We aimed to systematically review the effects of vitamin D supplementation during pregnancy on bone development and offspring growth.
Original paper ↗Read more →Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease
Endocrine complications such as impaired growth, delayed puberty, and low bone mineral density (BMD) can be associated with inflammatory bowel disease (IBD) in children and adolescents.
Original paper ↗Read more →Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa
AN participants received transdermal 17β-estradiol (continuously) with 10 days of cyclic oral progesterone (100 mg daily) every month for the study duration (AN-E+).
Original paper ↗Read more →Serum 25-hydroxyvitamin D concentrations in 16-year-old Icelandic adolescent and its association with bone mineral density
The aim of the study was to assess the potential association between serum 25-hydroxyvitamin D (25(OH)D) and whole-body bone mineral density (BMD) among 16-year-old adolescents and to study the prevalence of 25(OH)D insufficiency, defined as concentration under 50 nmol/l.
Original paper ↗Read more →The decline of vitamin D in adolescent athletes: insights from a one-year follow-up and its association with electrocardiographic changes
Annual health evaluations are essential for athletes to ensure fitness for competition and enable the early detection of emerging health issues.
Original paper ↗Read more →Vitamin D Maintains Growth and Bone Mineral Density against a Background of Severe Vitamin A Deficiency and Moderate Toxicity in a Swine Model
Pigs were weaned and randomized to four treatments (n = 13/group): −A−D, −A+D, +A−D, and +A+D for 3 and 5 wk.
Original paper ↗Read more →Vitamin D Receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of Juvenile and Adolescent Idiopathic Scoliosis patients
Quantitative data were compared by a nonparametric Mann Whitney U test.
Original paper ↗Read more →Vitamin D in Adolescent Growth and Bone Accrual: Study Summary
A clear summary of adolescent vitamin D research on bone growth, calcium absorption and hormones, including what the studies cannot establish.
Read more →Milk Intake, Sun Exposure, and Caffeinated Energy Drink Consumption in Children and Adolescents: Evidence, Uncertainty, and Implications for Peak Bone Mass Accrual
Background/Objectives: Childhood and adolescence are critical periods for bone mineral accrual and future skeletal reserve.
Original paper ↗Read more →Bone density, fractures and the associated factors in iranian children and adolescent with Osteogenesis Imperfecta
The purpose of this study was to assess the BMD and Vitamin D level in children with OI in southern Iran.
Original paper ↗Read more →Calcium Deficiency Rickets in African Adolescents: Cortical Bone Histomorphometry
Rickets due to dietary calcium deficiency has been well described in black African children, but less is known about this condition in black adolescents.
Original paper ↗Read more →Total Calcium Intake Is Associated With Trabecular Bone Density in Adolescent Girls With Type 1 Diabetes
The objective of this analysis was to evaluate the associations of total daily Ca intake with bone outcomes among youth with T1D.
Original paper ↗Read more →Effects of Adolescents’ Lifestyle Habits and Body Composition on Bone Mineral Density
This study investigated the factors influencing adolescents’ bone mineral density (BMD).
Original paper ↗Read more →Vitamin D and Calcium Intakes, Physical Activity, and Calcaneus BMC among School-Going 13-Year Old Malaysian Adolescents
Objective: To investigate the relationship between the dietary intake of calcium and vitamin D, physical activity, and bone mineral content (BMC) in 13-year-old Malaysian adolescents.
Original paper ↗Read more →Adequacy of calcium and vitamin D nutritional status in a nationally representative sample of Irish teenagers aged 13 to 18 years
In light of the key roles of vitamin D and calcium in adolescent bone health, there is a critical need for representative data on nutritional status for both micronutrients in teenagers.
Original paper ↗Read more →Efficacy of Danshen injection combined with Calcitriol and Calcium/Vitamin-D for the treatment of osteoporotic fractures: A retrospective case-control study
To explore the efficacy of Danshen injection combined with calcitriol and calcium/Vitamin-D in the treatment of osteoporotic fractures.
Original paper ↗Read more →Original sources
Effect of Vitamin D Replacement on Musculoskeletal Parameters in School Children: A Randomized Controlled Trial
Published in El-Hajj Fuleihan G et al. JCEM (2006).
Publication details
Effect of Vitamin D Replacement on Musculoskeletal Parameters in School Children: A Randomized Controlled Trial. El-Hajj Fuleihan G et al. JCEM. 2006;91:405 to 412. DOI: 10.1210/jc.2005-1436. Author-hosted full text (PDF).
A Randomized Trial of Vitamin D3 Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption
Published in Lewis RD et al. JCEM (2013).
Publication details
A Randomized Trial of Vitamin D3 Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption. Lewis RD et al. JCEM. 2013;98:4816 to 4825.
Relationships among Vitamin D Levels, Parathyroid Hormone, and Calcium Absorption in Young Adolescents
Published in Abrams SA et al. JCEM (2005).
Publication details
Relationships among Vitamin D Levels, Parathyroid Hormone, and Calcium Absorption in Young Adolescents. Abrams SA et al. JCEM. 2005;90:5576 to 5581.
A randomized clinical trial of vitamin D supplementation in healthy adolescents
Published in Putman MS et al. J Adolesc Health (2013).
Publication details
A randomized clinical trial of vitamin D supplementation in healthy adolescents. Putman MS et al. J Adolesc Health. 2013;52:592 to 598.
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial
Published in Ganmaa D et al. Lancet Diabetes Endocrinol (2024).
Publication details
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial. Ganmaa D et al. Lancet Diabetes Endocrinol. 2024;12:29 to 38. Final abstract only; not counted among the fully assessed studies.